The European Commission, acting with and on behalf of EU Member States through the Health Emergency Preparedness and Response Authority (HERA), and vaccine developers BioNTech-Pfizer, have reached an agreement to better address Member States’ assessment of evolving needs for COVID-19 vaccines. The amendment to the existing vaccines supply contract takes into account the improved epidemiological […]
Start of delivery of vaccines in response to the monkeypox outbreak
Yesterday, the delivery of the first vaccine doses purchased by the European Commission’s Health Emergency Preparedness and Response Authority (HERA) in response to the current monkeypox outbreak started, with an initial 5,300 doses arriving in Spain, out of the total 109,090 doses procured. It is the first of a series of deliveries that will take […]
EU-Latin America and Caribbean Partnership
At the European Development Days, Ursula von der Leyen, President of the European Commission, and Pedro Sánchez, Prime Minister of Spain, launched a new European Union – Latin America and Caribbean partnership on local manufacturing of vaccines, medicines and other health technologies, and strengthening health systems resilience, that will complement and further enhance social, economic and scientific […]
HERA secures monkeypox vaccines for EU Member states
On 14th June, HERA, the European Commission’s Health Preparedness and Response Authority, concluded a contract with the company Bavarian Nordic to purchase 109 090 doses of their 3rd generation vaccines in response to the current monkeypox outbreaks. As the number of cases continues to grow, this agreement will make vaccines rapidly available to all EU Member […]
Commission steps up funding to vaccination roll-out in Africa
The European Commission has announced its intention to step up funding to accelerate roll-out and uptake of vaccines and other COVID-19 tools in Africa, with a further €400 million in support. The Commission also foresees a €427 million euros ($450 million) contribution to the Global Pandemic Preparedness Fund to support efforts to prevent and better respond to […]
HORIZON EUROPE: Vaccines 2.0 – developing the next generation of vaccines
Expected outcome This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes: The […]
The EU and AstraZeneca agree on COVID-19 vaccine supply and on ending litigation
The EU and AstraZeneca have reached an agreement which will secure the delivery of the remaining COVID-19 vaccine doses to Member States under the terms of the Advance Purchase Agreement concluded on 27 August 2020 with AstraZeneca. The agreement will also end the pending litigation before the Brussels Court. Commissioner for Health and Food Safety […]
Commission mobilises €123 million for research and innovation to combat the threat of variants
The Commission is mobilising €123 million from Horizon Europe, the new EU research and innovation programme, for urgent research into coronavirus variants. This first emergency funding under Horizon Europe adds to a range of EU-funded research and innovation actions to fight the coronavirus and contributes to the Commission’s overall action to prevent, mitigate and respond to […]
Coronavirus variants: current status and impact on EU vaccination
Experts from the EMA, the European Centre for Disease Control and the WHO discussed coronavirus strains and vaccine efficacy with MEPs on 15 March. The Environment, Public Health and Food Safety Committee held a discussion on 15 March on Covid-19 variants and vaccine effectiveness with representatives from the European Medicines Agency, the European Centre […]